Wuhan Easy Diagnosis Biomedicine Co.,Ltd. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 625.93 million compared to CNY 7,469.96 million a year ago. Revenue was CNY 625.93 million compared to CNY 7,469.96 million a year ago.

Net income was CNY 145.3 million compared to CNY 3,838.4 million a year ago. Basic earnings per share from continuing operations was CNY 0.63 compared to CNY 16.83 a year ago. Diluted earnings per share from continuing operations was CNY 0.63 compared to CNY 16.58 a year ago.